We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
A new final rule from the U.S. Patent and Trademark Office (PTO) that would have gone into effect Nov. 1 has been put on hold for now after a district court judge granted GlaxoSmithKline’s (GSK) motion for a preliminary injunction.